Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acromegaly Therapy
Research from University of California broadens understanding of acromegaly therapy
April 27th, 2008
A new study, 'Medical therapy: options and uses,' is now available. "Since the initial use of medical treatment for acromegaly, several advances have been made in the understanding of the pathophysiology of growth hormone producing tumors, resulting in the development of multiple medical options and novel treatments. Currently there are three major classes of medication available for the treatment of acromegaly: somatostatin receptor ligands, growth hormone receptor antagonists, and dopamine agonists," investigators in the United States report. "Somatostatin receptor ligands are the treatment of choice for acromegaly due to their effectiveness in controlling growth...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-27)
|
